Načítá se...
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
U.S. SEER (Surveillance Epidemiology and End Results) data for age-adjusted mortality rates for all cancers combined for all races show only a modest overall 13% decline over the past 35 years. Moreover, the greatest contributor to cancer mortality is treatment-resistant metastatic disease. The acce...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3691519/ https://ncbi.nlm.nih.gov/pubmed/23805101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2013.00068 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|